140 related articles for article (PubMed ID: 37419021)
41. Optimal loading flow rate trajectory in monoclonal antibody capture chromatography.
Gomis-Fons J; Yamanee-Nolin M; Andersson N; Nilsson B
J Chromatogr A; 2021 Jan; 1635():461760. PubMed ID: 33271430
[TBL] [Abstract][Full Text] [Related]
42. Enhancing protein A productivity and resin utilization within integrated or intensified processes.
Brinkmann A; Elouafiq S
Biotechnol Bioeng; 2021 Sep; 118(9):3359-3366. PubMed ID: 33638385
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of Continuous Membrane Chromatography Concepts with an Enhanced Process Simulation Approach.
Zobel-Roos S; Stein D; Strube J
Antibodies (Basel); 2018 Mar; 7(1):. PubMed ID: 31544865
[TBL] [Abstract][Full Text] [Related]
44. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.
Godawat R; Brower K; Jain S; Konstantinov K; Riske F; Warikoo V
Biotechnol J; 2012 Dec; 7(12):1496-508. PubMed ID: 23070975
[TBL] [Abstract][Full Text] [Related]
45. Purification of monoclonal antibodies from clarified cell culture fluid using Protein A capture continuous countercurrent tangential chromatography.
Dutta AK; Tran T; Napadensky B; Teella A; Brookhart G; Ropp PA; Zhang AW; Tustian AD; Zydney AL; Shinkazh O
J Biotechnol; 2015 Nov; 213():54-64. PubMed ID: 25747172
[TBL] [Abstract][Full Text] [Related]
46. Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity.
Kamga MH; Cattaneo M; Yoon S
Prep Biochem Biotechnol; 2018 May; 48(5):383-390. PubMed ID: 29509101
[TBL] [Abstract][Full Text] [Related]
47. Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture.
Pollock J; Bolton G; Coffman J; Ho SV; Bracewell DG; Farid SS
J Chromatogr A; 2013 Apr; 1284():17-27. PubMed ID: 23453463
[TBL] [Abstract][Full Text] [Related]
48. Design and operation of a continuous integrated monoclonal antibody production process.
Steinebach F; Ulmer N; Wolf M; Decker L; Schneider V; Wälchli R; Karst D; Souquet J; Morbidelli M
Biotechnol Prog; 2017 Sep; 33(5):1303-1313. PubMed ID: 28691347
[TBL] [Abstract][Full Text] [Related]
49. Continuous downstream processing for high value biological products: A Review.
Zydney AL
Biotechnol Bioeng; 2016 Mar; 113(3):465-75. PubMed ID: 26153056
[TBL] [Abstract][Full Text] [Related]
50. Retrospective Evaluation of Cycled Resin in Viral Clearance Studies-A Multiple Company Collaboration.
Mattila J; Curtis S; Webb-Vargas Y; Wilson E; Galperina O; Roush D; Tobler S; Stanley B; Clark M; Weaver J; Pike J; Yu D; Li X; Flicker A; Kindermann J; Schuelke N; Whitcombe R; Bennett L
PDA J Pharm Sci Technol; 2019; 73(5):470-486. PubMed ID: 31101706
[TBL] [Abstract][Full Text] [Related]
51. Design of an integrated continuous downstream process for acid-sensitive monoclonal antibodies based on a calcium-dependent Protein A ligand.
Scheffel J; Isaksson M; Gomis-Fons J; Schwarz H; Andersson N; Norén B; Solbrand A; Chotteau V; Hober S; Nilsson B
J Chromatogr A; 2022 Feb; 1664():462806. PubMed ID: 35033788
[TBL] [Abstract][Full Text] [Related]
52. Protein A affinity chromatography of Chinese hamster ovary (CHO) cell culture broths containing biopharmaceutical monoclonal antibody (mAb): Experiments and mechanistic transport, binding and equilibrium modeling.
Grom M; Kozorog M; Caserman S; Pohar A; Likozar B
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():44-56. PubMed ID: 29522957
[TBL] [Abstract][Full Text] [Related]
53. Integrated system for temperature-controlled fast protein liquid chromatography. III. Continuous downstream processing of monoclonal antibodies.
Ketterer B; Moore-Kelly C; Thomas ORT; Franzreb M
J Chromatogr A; 2020 Jan; 1609():460429. PubMed ID: 31431354
[TBL] [Abstract][Full Text] [Related]
54. Validation and optimization of viral clearance in a downstream continuous chromatography setting.
Chiang MJ; Pagkaliwangan M; Lute S; Bolton G; Brorson K; Schofield M
Biotechnol Bioeng; 2019 Sep; 116(9):2292-2302. PubMed ID: 31112283
[TBL] [Abstract][Full Text] [Related]
55. Fully integrated downstream process to enable next-generation manufacturing.
Ramos I; Sharda N; Villafana R; Hill-Byrne K; Cai K; Pezzini J; Coffman J
Biotechnol Bioeng; 2023 Jul; 120(7):1869-1881. PubMed ID: 36950907
[TBL] [Abstract][Full Text] [Related]
56. Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm.
Arnold L; Lee K; Rucker-Pezzini J; Lee JH
Biotechnol J; 2019 Feb; 14(2):e1800061. PubMed ID: 29729129
[TBL] [Abstract][Full Text] [Related]
57. Gamma irradiating chromatography columns enables bioburden-free integrated continuous biomanufacturing.
Varner C; Patil R; Godawat R; Warikoo V; Konstantinov K; Brower KP
Biotechnol J; 2021 Apr; 16(4):e2000298. PubMed ID: 33314754
[TBL] [Abstract][Full Text] [Related]
58. A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode.
Shamashkin M; Godavarti R; Iskra T; Coffman J
Biotechnol Bioeng; 2013 Oct; 110(10):2655-63. PubMed ID: 23633385
[TBL] [Abstract][Full Text] [Related]
59. Oncolytic virus purification with periodic counter-current chromatography.
Mendes JP; Silva RJS; Berg M; Mathiasson L; Peixoto C; Alves PM; Carrondo MJT
Biotechnol Bioeng; 2021 Sep; 118(9):3522-3532. PubMed ID: 33818758
[TBL] [Abstract][Full Text] [Related]
60. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
Garcia FA; Vandiver MW
PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
